
Board Meeting26 Dec 2025, 06:33 pm
Eiko Lifesciences Ltd Closes Trading Window for Quarter Ending 31st December, 2025
AI Summary
Eiko Lifesciences Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the company's Code of Conduct. The closure is effective from Thursday, 015t January, 2026 until 48 hours after the Board Meeting where the approval of Un-Audited Standalone and Consolidated Financial Results for the quarter ending 31st December, 2025 will be considered. The date of the Board Meeting will be intimated separately.
Key Highlights
- Eiko Lifesciences Ltd closes trading window for quarter ending 31st December, 2025
- Closure is in accordance with SEBI regulations and the company's Code of Conduct
- Closure effective from Thursday, 015t January, 2026
- Closure to remain in effect until 48 hours after the Board Meeting
- Date of Board Meeting to be intimated separately
Price Impact
More from EIKO